In an article for Bloomberg Law, Latham lawyers discuss the US Department of Justice’s evolving enforcement priorities impacting the medical device sector.
Medical device companies remain in the Department of Justice’s crosshairs. False Claims Act recoveries totaled $6.8 billion in fiscal year 2025, with more than 83% related to health-care matters. Nearly one-third of those recoveries came from non-intervened actions, underscoring the growing appetite of qui tam relators to litigate independently.
